Loading market dashboard
CEL-SCI Corporation
CVMHealthcareAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reported financial results for three months ended March 31, 2026, as well as key corporate developments for Multikine.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of public offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation Announces Pricing of Public Offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia.
SÃO PAULO, April 30, 2026 /PRNewswire/ -- Itaú Unibanco Holding S.A. (the "Company") announces to the market that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC") on April 29, 2026.
Cel-Sci Corporation (NYSEAMERICAN:CVM - Get Free Report) was down 0.9% on Thursday. The stock traded as low as $3.27 and last traded at $3.31. Approximately 30,767 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 62,532 shares. The stock had previously closed at $3.34. Cel-Sci Stock Down
Cel-Sci Corporation (NYSEAMERICAN:CVM - Get Free Report)'s stock price shot up 6.9% on Wednesday. The company traded as high as $3.60 and last traded at $3.43. 52,583 shares traded hands during trading, an increase of 56% from the average session volume of 33,663 shares. The stock had previously closed at $3.21. Cel-Sci Stock Up
